Seres Therapeutics Inc (MCRB)
0.6179
-0.04
(-5.62%)
USD |
NASDAQ |
Apr 15, 16:00
0.6202
0.00 (0.00%)
After-Hours: 20:00
Seres Therapeutics Debt to Equity Ratio: -2.264 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.264 |
| September 30, 2023 | -6.688 |
| June 30, 2023 | 4.455 |
| March 31, 2023 | -1.070 |
| December 31, 2022 | 4.734 |
| September 30, 2022 | 0.7525 |
| June 30, 2022 | 2.196 |
| March 31, 2022 | 0.623 |
| December 31, 2021 | 0.1874 |
| September 30, 2021 | 0.1449 |
| June 30, 2021 | 0.2507 |
| March 31, 2021 | 0.1754 |
| December 31, 2020 | 0.1436 |
| September 30, 2020 | 0.1328 |
| June 30, 2020 | -0.3792 |
| March 31, 2020 | -0.4015 |
| Date | Value |
|---|---|
| December 31, 2019 | -0.5101 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-6.688
Minimum
Sep 2023
4.734
Maximum
Dec 2022
0.1307
Average
0.1436
Median
Dec 2020
Debt to Equity Ratio Benchmarks
| Integra Lifesciences Holdings Corp | 0.9444 |
| Nuwellis Inc | 0.00 |
| Axogen Inc | 0.4871 |
| Axsome Therapeutics Inc | 0.9324 |
| 908 Devices Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 358.60M |
| Total Liabilities (Quarterly) | 403.46M |
| Shareholders Equity (Quarterly) | -44.86M |
| Current Ratio | 1.778 |
| Net Debt Paydown Yield | -5.36% |